Last updated on July 2020

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Brief description of study

Primary Objective:

To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)

Secondary Objectives:

To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation

To continue to assess the safety and tolerability throughout the study

Detailed Study Description

Duration per participant is up to 28 weeks.

Clinical Study Identifier: NCT04033367

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.